Molina Investors Face Dec. 2 Deadline in Securities Class Action Over 2025 Guidance Cut
Plaintiffs’ firms are vying for lead status over claims that Molina concealed rising medical costs.
Overview
- Rosen Law Firm, The Schall Law Firm, DJS Law Group, and Kahn Swick & Foti are soliciting shareholders to seek lead‑plaintiff roles before the court’s deadline.
- The case covers purchases of Molina Healthcare securities from February 5, 2025 through July 23, 2025.
- The complaint alleges failures to disclose adverse medical cost trend assumptions and a dislocation between premium rates and medical costs, with near‑term growth tied to low service utilization.
- Statutory claims assert violations of Sections 10(b) and 20(a) of the Exchange Act and SEC Rule 10b‑5 in a case pending in the U.S. District Court for the Central District of California.
- Filings cite Molina’s July 23, 2025 guidance cut and a subsequent 16.84% share drop to $158.22 as the event that revealed the alleged issues to investors.